Search Results - "Fofana, Fatoumata"

Refine Results
  1. 1

    Applying a mixed methods design to test saturation for qualitative data in health outcomes research by Fofana, Fatoumata, Bazeley, Pat, Regnault, Antoine

    Published in PloS one (19-06-2020)
    “…Saturation, a core concept in qualitative research, suggests when data collection might end. It is reached when no new relevant information emerges with…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma by Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael

    Published in Health and quality of life outcomes (22-12-2017)
    “…No validated disease-specific questionnaires exist to capture health-related quality of life (HRQoL) in patients with Merkel cell carcinoma (MCC). The…”
    Get full text
    Journal Article
  4. 4

    Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma by Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael

    Published in Health and quality of life outcomes (27-03-2019)
    “…Health and Quality of Life Outcomes (2017) 15:247 https://doi.org/10.1186/s12955-017-0815-5 Unfortunately, the original version of this article [1] contained…”
    Get full text
    Journal Article
  5. 5

    Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis by Kwatra, Shawn G., Rodriguez, Danielle, Dias-Barbosa, Carla, Budhiarso, Ismail, Fofana, Fatoumata, Vernon, Margaret, Gabriel, Sylvie, Piketty, Christophe, Puelles, Jorge

    Published in Dermatology and therapy (01-10-2023)
    “…Introduction Validated patient report tools for quantifying patient experiences of itch in prurigo nodularis (PN) are limited. This study aimed to evaluate the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis by Ständer, Sonja, Fofana, Fatoumata, Dias-Barbosa, Carla, Rodriguez, Danielle, Budhiarso, Ismail, Jabbar-Lopez, Zarif K., Piketty, Christophe, Vernon, Margaret, Puelles, Jorge

    Published in Dermatology and therapy (01-07-2023)
    “…Introduction Sleep is often disturbed in patients with prurigo nodularis (PN). To address the lack of validated patient-reported outcome (PRO) measures for…”
    Get full text
    Journal Article
  8. 8

    Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials by Dias-Barbosa, Carla, Silverberg, Jonathan I., Ständer, Sonja, Rodriguez, Danielle, Fofana, Fatoumata, Filipenko, Dina, Ulianov, Liliana, Piketty, Christophe, Puelles, Jorge

    Published in Journal of patient-reported outcomes (15-07-2024)
    “…Background Patient-focused approaches to capturing day-to-day variability in sleep disturbance are needed to properly evaluate the sleep benefits of new…”
    Get full text
    Journal Article
  9. 9
  10. 10

    An explanatory sequential mixed-methods design to establish thresholds of within-individual meaningful change on a sleep disturbance numerical rating scale score in atopic dermatitis by Dias-Barbosa, Carla, Puelles, Jorge, Fofana, Fatoumata, Gabriel, Sylvie, Rodriguez, Danielle, Chavda, Rajeev, Piketty, Christophe

    Published in Quality of life research (01-03-2023)
    “…Purpose Establishing a meaningful within-individual change (MWIC) threshold is a key aspect for interpreting scores used as endpoints for evaluating treatment…”
    Get full text
    Journal Article
  11. 11

    Non-progression during avelumab treatment is associated with clinically relevant improvements in health-related quality of life in patients with Merkel cell carcinoma by Bharmal, Murtuza, Fofana, Fatoumata, Mahnke, Lisa, Schlichting, Michael, Kaufman, Howard

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e21070 Background: There is little data on quality of life (QoL) for patients (pts) with Merkel cell carcinoma (MCC). To better understand how…”
    Get full text
    Journal Article
  12. 12

    Mesanthemum tuberosum Lecomte resurrected from M. prescottianum (Bong.) Körn. (Eriocaulaceae), variation and lectotypification by Phillips, Sylvia M., Fofana, Fatoumata, Cheek, Martin

    Published in Kew bulletin (01-04-2018)
    “…Mesanthemum prescottianum is a West African species occurring in the uplands extending from Guinea to Ivory Coast. Variation within the species is discussed…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Monitoring Severity of Respiratory Syncytial Virus : Results of Initial Quantitative Validation by de la Loge, Christine, Fofana, Fatoumata, Williams, Paul, Rusch, Sarah, Stevens, Marita, Scott, Jane

    Published in Patient related outcome measures (30-09-2021)
    “…Purpose: PRESORS ClinRO completed by clinicians and ObsRO completed by caregivers were developed to characterize the clinical course of respiratory syncytial…”
    Get full text
    Journal Article
  15. 15

    Monitoring Severity of Respiratory Syncytial Virus by de la Loge, Christine, Rusch, Sarah, Fofana, Fatoumata, Stevens, Marita, Williams, Paul, Scott, Jane

    Published in Patient related outcome measures (30-09-2021)
    “…Purpose: PRESORS ClinRO completed by clinicians and ObsRO completed by caregivers were developed to characterize the clinical course of respiratory syncytial…”
    Get full text
    Journal Article
  16. 16

    Comparative effectiveness of avelumab versus chemotherapy in Merkel cell carcinoma: innovative use of patient insights by Bharmal, Murtuza, Marrel, Alexia, Hennessy, Meliessa, Fofana, Fatoumata, Lambert, Jérémy, Arnould, Benoit

    “…To assess patient experience with chemotherapy and avelumab in metastatic Merkel cell carcinoma (mMCC). In the JAVELIN Merkel 200 trial,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20